Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction

Placenta

Volumn 42, Issue , 2016, Pages 1-8

  Benton, Samantha J ^a   McCowan, Lesley M ^b   Heazell, Alexander E P ^c   Grynspan, David ^d   Hutcheon, Jennifer A ^a   Senger, Christof ^e   Burke, Orlaith ^f   Chan, Yuen ^b   Harding, Jane E ^g   Yockell Lelièvre, Julien ^h   Hu, Yuxiang ^a   Chappell, Lucy C ⁱ   Griffin, Melanie J ⁱ   Shennan, Andrew H ⁱ   Magee, Laura A ^a,k   Gruslin, Andrée ^j   von Dadelszen, Peter ^a,k  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^e CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY OF AUCKLAND   (New Zealand)

^h OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

ⁱ ST THOMAS HOSPITAL   (United Kingdom)

^j UNIVERSITY OF OTTAWA   (Canada)

^k UNIVERSITY OF LONDON   (United Kingdom)

more..

Author keywords

Diagnosis; Fetal growth restriction; Placental dysfunction; Placental growth factor; Placental lesions

Indexed keywords

BIOLOGICAL MARKER; PLACENTAL GROWTH FACTOR;

ABDOMINAL CIRCUMFERENCE; ADULT; ARTICLE; FEMALE; FETAL GROWTH RESTRICTION; FETUS GROWTH; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; PLACENTA DISORDER; PLACENTA TISSUE; PREDICTIVE VALUE; PRIORITY JOURNAL; STILLBIRTH; UMBILICAL ARTERY; BLOOD; FETAL GROWTH RETARDATION; FETUS ECHOGRAPHY; OBSTETRIC DELIVERY; PATHOLOGY; PLACENTA; PLACENTAL INSUFFICIENCY; PREGNANCY; YOUNG ADULT;

ADULT; BIOMARKERS; DELIVERY, OBSTETRIC; FEMALE; FETAL GROWTH RETARDATION; HUMANS; PLACENTA; PLACENTA GROWTH FACTOR; PLACENTAL INSUFFICIENCY; PREGNANCY; ULTRASONOGRAPHY, PRENATAL; YOUNG ADULT;

EID: 84977633832     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2016.03.010     Document Type: Article

References (39)

1. [1] Breeze, A.C.G., Lees, C.C., Prediction and perinatal outcomes of fetal growth restriction. Semin. Fet Neonat. Med. 12:5 (2007), 383–397.
2. [2] Garite, T.J., Clark, R., Thorp, J.A., Intrauterine growth restriction increases morbidity and mortality among premature neonates. Am J Obstet Gynecol. 191:2 (2004), 481–487.
3. [3] Halliday, H.L., Neonatal management and long-term sequelae. Best. Prac. Res. Clin. Obstet. 23:6 (2009), 871–880.
4. [4] Royal College of Obstetricians and Gynaecologists UK, Green-top Guideline No. 31: the Investigation and Management of the Small-for Gestational-age Fetus. 2013 www.rcog.org.uk/clinical-guidance.
5. [5] Figueras, F., Gratacos, E., Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagn. Ther. 36:2 (2014), 86–98.
6. [6] American College of Obstetricians and Gynecologists (ACOG), Practice bulletin number 134: fetal growth restriction. Obstet. Gynecol. 121 (2013), 1122–1133.
7. [7] Zhang, J., Merialdi, M., Platt, L.D., Kramer, M.S., Defining normal and abnormal fetal growth: promises and challenges. Am. J. Obstet. Gynecol. 202:6 (2010), 522–528.
8. [8] Soothill, P.W., Bobrow, C.S., Holmes, R., Small for gestational age is not diagnosis. Ultrasound Obstet. Gynecol. 13 (1999), 225–228.
9. [9] Benton, S.J., Hu, Y., Fang, X., et al. Can placental growth factor identify placental intrauterine growth restriction in small for gestational age fetuses?. Am. J. Obstet. Gynecol., 206(2), 2012, 163 e1-7.
10. [10] Magee, L.A., Pels, A., Helewa, M., Rey, E., von Dadelszen, P., SOGC clinical practice guideline: diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J. Obstet. Gynaecol. Can. 36:5 (2014), 416–438.
11. [11] Acharya, G., Wilsgaard, T., Berntsen, G.K.R., Maltau, J.M., Kiserud, T., Reference ranges for serial measurements of umbilical artery Doppler indices in the second half of pregnancy. Am. J. Obstet. Gynecol. 192 (2005), 937–944.
12. [12] Kramer, M., Platt, R., Wen, S., et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 108:2 (2001), e35–42.
13. [13] McCowan, L.M.E., Harding, J.E., Roberts, A.B., et al. A pilot randomized controlled trial of two regimens of fetal surveillance for small-for-gestational-age fetuses with normal results of umbilical artery Doppler velocimetry. Am. J. Obstet. Gynecol. 182:1 (2000), 81–86.
14. [14] McCowan, L., Harding, J., Roberts, A., et al. Administration of low dose aspirin to mothers with small for gestational age fetuses and abnormal umbilical Doppler studies to increase birthweight: a randomised double-blind controlled trial. BJOG 106 (1999), 647–651.
15. [15] McCowan, L.M.E., Harding, J., Stewart, A.W., Customised birthweight centiles predict SGA pregnancies with perinatal morbidity. BJOG 112 (2005), 1026–1033.
16. [16] McCowan, L.M.E., Harding, J.E., Stewart, A.W., Umbilical artery Doppler studies in small for gestational age babies reflect disease severity. BJOG 107 (2000), 916–925.
17. [17] Guaran, R.L., Wein, P., Sheedy, M., Walstab, J., Beischer, N.A., Update of growth percentiles for infants born in an Australian population. Aust. N. Z. J. Obstet. Gynaecol. 34 (1994), 39–50.
18. [18] Griffin, M., Seed, P., Webster, L., et al. Diagnostic accuracy of placental growth factor and ultrasound parameters to predict the small-for-gestational-age infant in women presenting with reduced symphysis-fundal height measurement. Ultrasound Obstet. Gynecol. 46:2 (2015), 182–190.
19. [19] Benton, S.J., Hu, Y., Fang, X., et al. Placental growth factor as a diagnostic test for pre-eclampsia: A performance comparison of two immunoassays. Am. J. Obstet. Gynecol., 205(5), 2011, 469 e1-8.
20. [20] Saffer, C., Olson, G., Boggess, K.A., et al. Determination of placental growth factor (PlGF) in healthy pregnant women without signs or symptoms of preeclampsia. Pregnancy Hypertens. 3:2 (2013), 124–132.
21. [21] Warrander, L.K., Batra, G., Bernatavicius, G., et al. Maternal perception of reduced fetal movements is associated with altered placental structure and function. PLoS One, 7(4), 2012, e34851, 10.1371/journal.pone.0034851.
22. [22] Redline, R.W., Ariel, I., Baergen, R.N., et al. Fetal vascular obstructive lesions: nosology and reproducibility of placental reaction patterns. Pediatr. Dev. Pathol. 7:5 (2004), 443–452.
23. [23] Redline, R.W., Boyd, R., Campbell, V., et al. Maternal vascular underperfusion: nosology and reproducibility of placental reaction patterns. Pediatr. Dev. Pathol. 7:3 (2004), 237–249.
24. [24] Redline, R.W., Faye-Petersen, O., Heller, D., et al. Amniotic infection syndrome: nosology and reproducibility of placental reactions patterns. Pediatr. Dev. Pathol. 6:5 (2003), 435–448.
25. [25] Taylor, R.N., Grimwood, J., Taylor, R.S., et al. Longitudinal serum concentrations of placental growth factor: Evidence for abnormal placental angiogenesis in pathologic pregnancies. Am. J. Obstet. Gynecol. 188:1 (2003), 177–182.
26. [26] Levine, R.J., Lam, C., Qian, C., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N. Engl. J. Med. 355:10 (2006), 992–1005.
27. [27] Powers, R.W., Roberts, J.M., Plymire, D.A., et al. Low placental growth factor across pregnancy identifies a subset of women with preterm preeclampsia. Hypertension. 60:1 (2012), 239–246.
28. [28] Robinson, C.J., Johnson, D.D., Chang, E.Y., Armstrong, D.M., Wang, W., Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am. J. Obstet. Gynecol. 195:1 (2006), 255–259.
29. [29] Chappell, L.C., Duckworth, S., Seed, P.T., et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation 128:19 (2013), 2121–2131.
30. [30] Wallner, W., Sengenberger, R., Strick, R., et al. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin. Sci. Lond. 112:1 (2007), 51–57.
31. [31] Levine, R., Lam, C., Qian, C., et al. Soluble endoglin and other circulating angiogenic factors in normotensive pregnancy with fetal growth restriction. Am. J. Obstet. Gynecol. 193:6 (2005), 229–235.
32. [32] Ong, C.Y.T., Liao, A.W., Cacho, A.M., Spencer, K., Nicolaides, K.H., First-trimester maternal serum levels of placenta growth factor as predictor preeclampsia and fetal growth restriction. Am. J. Obstet. Gynecol. 98:4 (2001), 608–611.
33. [33] Romero, R., Nien, J.K., Espinoza, J., et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J. Matern. Fetal Neonatal Med. 21:1 (2008), 9–23.
34. [34] Triunfo, S., Lobmaier, S., Parra-Saavedra, M., et al. Angiogenic factors at diagnosis of late-onset small-for-gestational age and histological placenta underperfusion. Placenta 35:6 (2014), 398–403.
35. [35] Chaiworapongsa, T., Romero, R., Whitten, A.E., et al. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia. J Matern. Fetal Neonatal Med. 25 (2015 Aug), 1–15 [Epub ahead of print].
36. [36] Ptacek, I., Smith, A., Garrod, A., et al. Quantitative assessment of placental morphology may identify specific causes of stillbirth. BMC Clin. Pathol. 16:1 (2016), 1–12.
37. [37] Redline, R., The clinical implications of placental diagnoses. Semin. Perinatol. 39:1 (2015), 2–8.
38. [38] Dutton, P.J., Warrander, L.K., Roberts, S.A., et al. Predictors of poor perinatal outcome following maternal perception of reduced fetal movements – a prospective cohort study. PLoS One, 7(7), 2012, e39784, 10.1371/journal.pone.0039784.
39. [39] Higgins, L.E., Johnstone, E.D., Myers, J., Sibley, C.P., Heazell, A.E.P., Placental assessment aids identification of pregnancies with reduced fetal movement who experience adverse outcome. BJOG., 2015 Supplement.